Menu:

Eflornithine hydrochloride

Eflornithine is a drug manufactured by Sanofi-Aventis, which has various uses. It was initially developed as a cancer medication; and while it has no significant effects on cancerous malignancies, it was found to be very effective as a hair-removing agent. The notion that topical application of eflornithine hydrochloride can reduce hair growth probably stems from the hair-loss side effect from this drug, when it is taken orally. It is the active ingredient in Vaniqa brand hair removal cream.

As a topical application, the drug has been shown to be an effective hair growth retardant in some patients, and is sold under the brand name Vaniqa (eflornithine hydrochloride 13.9%).

Studies submitted to Food and Drug Administration (FDA) observed that about 58% women using it on facial hair had significant results. It also suggested that this agent might be particularly effective in postmenopausal women. Moreover, Vaniqa rarely caused side effects such as acne, follicle irritation, itching or dryness.

How it works?

Who all should stay away from this drug?

It is important that you use your own good judgement whether to use these products or not. Results are not full proof and in majority of the time, you might not be happy with the outcome. If you think its worth the risk , then give it a try.